Published in Cancer Biother Radiopharm on August 01, 1997
Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis. Ann Thorac Surg (1996) 1.61
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation (2001) 1.53
Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Clin Nephrol (1999) 1.43
Comparison between intercostal and diaphragmatic flap in the surgical treatment of early bronchopleural fistula. Eur J Cardiothorac Surg (1997) 1.39
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Ital J Gastroenterol Hepatol (1999) 1.39
Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother (1996) 1.32
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol (1986) 1.20
Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells. Cell Immunol (1989) 1.02
Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol (1983) 1.01
Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation (2001) 0.98
Liver transplantation in the presence of portal vein thrombosis: report from a single center. Transplant Proc (2004) 0.93
Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer. Cancer Immunol Immunother (2000) 0.93
Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology (1999) 0.91
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. Int J Cancer (1997) 0.89
Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience. Ren Fail (2001) 0.89
CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood (2001) 0.88
Reconstruction of the nasal dorsum with autologous rib cartilage. Ann Plast Surg (2006) 0.87
Bcl-2 and drugs used in the treatment of cancer: new strategies of biotherapy which should not be underestimated. Cancer Biother Radiopharm (1998) 0.87
Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations. Cancer Immunol Immunother (1994) 0.87
Cell mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients. Eur J Cancer (1991) 0.86
Infectious complications in the renal transplant recipient. Transplant Proc (2005) 0.86
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects. Ric Clin Lab (1989) 0.86
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing. Tissue Antigens (2004) 0.86
The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back. Cancer Immunol Immunother (1998) 0.85
Pregnancy in renal transplantation. Clinical aspects. Clin Exp Obstet Gynecol (1984) 0.85
Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother (1999) 0.85
The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int Suppl (1985) 0.84
HLA-B5 and Behçet's disease. Tissue Antigens (1979) 0.84
Late symptomatic venous stenosis in three hemodialysis patients without previous central venous catheters. Artif Organs (2000) 0.84
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients. Anticancer Res (1996) 0.83
Comparison between HLA-DR serologic typing and oligotyping in kidney transplant: a single center experience. Transplant Proc (1993) 0.83
Activation of 5-lipoxygenase and related cell membrane lipoperoxidation in hemodialysis patients. J Am Soc Nephrol (1999) 0.83
Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg (1998) 0.83
Sentinel lymphadenectomy in cutaneous melanoma. Tumori (2002) 0.83
Use of mycophenolate mofetil in liver transplantation: a literature review. Transplant Proc (2005) 0.83
Pattern visual evoked potentials and brainstem auditory evoked responses in uremic patients. Acta Neurol Belg (1982) 0.83
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. Transplant Proc (1999) 0.82
A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis. Int Angiol (1989) 0.82
Gigantomastia and breast lumps in a kidney transplant recipient. Transplant Proc (1999) 0.82
Prospective randomized trial of submucosal hemorrhoidectomy with radiofrequency bistoury vs. conventional Parks' operation. Tech Coloproctol (2004) 0.82
Autologous cartilage graft rhinoplasties. Aesthetic Plast Surg (2006) 0.81
Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Cancer Res (1996) 0.81
Marginal donors in liver transplantation. Transplant Proc (2004) 0.81
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation (1999) 0.81
Radiofrequency fistulectomy vs. diathermic fistulotomy for submucosal fistulas: a randomized trial. Eur Rev Med Pharmacol Sci (2004) 0.80
Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Exp Neurol (1996) 0.80
Immunosorbent treatment in myasthenia gravis. Prog Clin Biol Res (1990) 0.80
HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. Transplant Proc (2009) 0.80
The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments. Cancer Biother Radiopharm (2000) 0.80
Correlation between genetic HLA class I and II polymorphisms and anthropological aspects in the Chaouya population from Morocco (Arabic speaking). Tissue Antigens (2010) 0.80
Echographic valuation of risk factors for cardiovascular disease in patients with renal transplantation. Transplant Proc (2001) 0.80
Usefulness of the Nd:YAG laser in parenchyma-sparing resection of pulmonary nodular lesions. Tumori (1994) 0.80
Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. Int J Immunopathol Pharmacol (2010) 0.79
IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer. Cancer Biother Radiopharm (1997) 0.79
Cardiac function and oxygen balance in septic patients during continuous hemofiltration. Blood Purif (1998) 0.79
Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. Neuroimmunomodulation (1998) 0.79
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. Transplant Proc (1997) 0.79
Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes. Diabetologia (1986) 0.79
Immunological aspects of chronic uremia. Kidney Int Suppl (1978) 0.79
En bloc minimal laser resection for T3-chest wall lung cancer in patients with poor pulmonary function. Chest (1996) 0.79
Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen. J Clin Oncol (1996) 0.79
Myasthenia gravis (MG) treatment with immunoadsorbent columns. Biomater Artif Cells Immobilization Biotechnol (1991) 0.79
Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron (1984) 0.79
Rhomboid flap procedure for pilonidal sinus: results from 67 cases. Int J Colorectal Dis (1998) 0.79
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids. Transplant Proc (1999) 0.79
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. Int J Immunopathol Pharmacol (2010) 0.79
[The endorectal repair of rectovaginal fistulae]. Minerva Chir (1999) 0.78
High-pressure perfusion versus gravity perfusion in liver harvesting: results from a prospective randomized study. Transplant Proc (2001) 0.78
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia. J Psychiatr Res (1989) 0.78
Infectious complications in renal transplant recipients. Transplant Proc (2005) 0.78
Hepatitis C virus infection in Italian kidney graft recipients. Changing risk factors and hepatitis C virus genotypes. Ital J Gastroenterol Hepatol (1997) 0.78
Inhibitory effects of anti-HLA-A, B, C heavy chain and anti-beta 2 microglobulin monoclonal antibodies on alloantigen and microbial antigen-induced immune responses in vitro. Scand J Immunol (1987) 0.78
Randomized study on in situ liver perfusion techniques: gravity perfusion vs high-pressure perfusion. Transplant Proc (1997) 0.78
Renal allograft immune response is influenced by patient and donor cytokine genotypes. Transplant Proc (2007) 0.78
Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm (1996) 0.78